中文         English  
  產品分類  
原料藥
醫藥中間體
工藝開發產品
定制化學品
優勢產品
工藝技術轉讓
 
   產品搜索
  
      
  
 
 
產品展示 您現在的位置是:首頁 >> 產品展示 >> 原料藥 
 
ACY-1215
 

ACY-1215 Rocilinostat; ACY1215; ACY 1215) CAS 1316214-52-4

Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM; >10-fold more selective for HDAC6 than HDAC1/2/3 (class I HDACs) with slight

ACY-1215的生物活性

Rocilinostat (ACY-1215) is a selective HDAC6 inhibitor with IC50 of 5 nM; >10-fold more selective for HDAC6 than HDAC1/2/3 (class I HDACs) with slight activity against HDAC8, minimal activity against HDAC4/5/7/9/11, Sirtuin1, and Sirtuin2.
IC50 Value: 5 nM
Target: HDAC6
in vitro: ACY-1215 is a hydroxamic acid derivative. ACY-1215 is 12-, 10-, and 11-fold less active against HDAC1, HDAC2, and HDAC3 (class I HDACs), respectively. ACY-1215 has minimal activity (IC50 > 1μM) against HDAC4, HDAC5, HDAC7, HDAC9, HDAC11, Sirtuin1, and Sirtuin2, and has slight activity against HDAC8 (IC50 = 0.1μM). The IC50 values for ACY-1215 for T-cell toxicity is 2.5μM. ACY-1215 overcomes tumor cell growth and survival conferred by BMSCs and cytokines in the BM milieu. ACY-1215 in combination with bortezomib induces synergistic anti-MM activity. ACY-1215 induces potent acetylation of α-tubulin at very low doses and triggers acetylation of lysine on histone H3 and histone H4 only at higher doses, confirming its specific inhibitory effect on HDAC6 activity.
in vivo: ACY-1215 in combination with bortezomib triggered more significant anti-MM activity than either agent alone in suppressing tumor growth and prolonging survival in both plasmacytoma model and disseminated MM model without significant adverse effects. ACY-1215 is readily absorbed by tumor tissue. Moreover, the drug does not accumulate in tumor tissue, as evidenced by the parallel decline of acetylated α-tubulin in blood cells and tumor tissue by 24 hours after dose.

化學信息

分子量 433.5 儲存條件 參考CoA中推薦的條件進行儲存。
分子式 C24H27N5O3
CAS號 1316214-52-4
溶劑/溶解度 DMSO 85 mg/ml; Water <1 mg/ml

返回上一頁
 
關于我們 | 產品展示 | 新聞中心 | 設備展示 | 客戶留言 | 聯系我們 版權所有:上海凱裕醫藥科技有限公司  技術支持網至普網站建設